Key points are not available for this paper at this time.
Overall response rate to immune checkpoint inhibitors was comparable across histological types. However, overall survival was worse for patients with tumors containing neuroendocrine features. Variant urothelial carcinoma should not exclude patients from receiving immune checkpoint inhibitors.
Building similarity graph...
Analyzing shared references across papers
Loading...
Natalie Miller
Ali Raza Khaki
Leonidas Nikolaos Diamantopoulos
The Journal of Urology
Harvard University
University of Washington
University of California, Los Angeles
Building similarity graph...
Analyzing shared references across papers
Loading...
Miller et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d8ae98183921ebcaae3538 — DOI: https://doi.org/10.1097/ju.0000000000000761